Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05952037
Title Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenstrom's Macroglobulinemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | AUS

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
Concord Repatriation General Hospital RECRUITING Concord New South Wales 2139 Australia Details
Flinders Medical Centre RECRUITING Bedford PK South Australia 5042 Australia Details
Monash Health RECRUITING Clayton Victoria 3168 Australia Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan 450000 China Details
Institute of Hematology and Hospital of Blood Disease RECRUITING Tianjin Tianjin 300020 China Details
Chu Clermont Ferrand Therapie Cellulaire and Hematolo RECRUITING Clermont Ferrand 63003 France Details
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda RECRUITING Milano 20162 Italy Details
Irccs Policlinico San Matteo, Universita Degli Studi Di Pavi RECRUITING Pavia 27100 Italy Details
Hospital Universitario Fundacion Jimenez Diaz RECRUITING Madrid 28040 Spain Details
Churchill Hospital Oxford University Hospital Nhs Trust RECRUITING Headington OX3 7LE United Kingdom Details
St Jamess University Hospital RECRUITING Leeds LS9 7TF United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field